Many genes, whose function may be affected by selected SNPs, have been investigated in the context of BP regulation in vivo, and previous studies linking genetics of hypertension to lymphocyte biology focused on SH2B3 as key driver for hypertension (Table VIII in the Data Supplement). This evidence concerns the gene SH2B3 and hypertensive disorder.